Patent · US Active

Compositions and methods for treating schizophrenia

US10799493B2 · kind B2 · utility

2Cited by

6References

20Claims

0Family size

Assignee

Minerva Neurosciences, Inc. · US

Inventors

Remy LUTHRINGER · Geneva, CH
Nadine Noel · Paris, FR
Sandra WERNER · Ostwald, FR

Key dates

Filing date	Mar 1, 2019
Grant date	Oct 13, 2020
Priority date	—
Expiry date	Mar 1, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure provides a novel polymorph of Compound (I): 2-((1-(2-(4-Fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one monohydrochloride dihydrate, i.e., Form (A) of Compound (I).HCl.2H2O. Pharmaceutical compositions comprising Form (A) of Compound (I).HCl.2H2O and related methods of treatment are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.